Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
7,113 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05882253 | Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)(IMAGINED) | recruiting | N/A | 225 | University of California, San DiegoOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT06099743 | ASCENT Intervention for Brain Tumor Patients | recruiting | N/A | 100 | Massachusetts General HospitalOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT07062172 | Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer | recruiting | N/A | 1,753 | University of California, IrvineOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT07058571 | Lifestyle Intervention for Veterans With Blood Cancer: Tele-Intervention | recruiting | N/A | 30 | VA Pittsburgh Healthcare SystemFED | 1 | Jul 10, 2025 | clinicaltrials |
| NCT05086692 | A Beta-only IL-2 ImmunoTherapY Study(ABILITY-1) | recruiting | Phase 1 / Phase 2 | 115 | Medicenna Therapeutics, Inc.INDUSTRY | 7 | Jul 9, 2025 | clinicaltrials |
| NCT05396612 | Role of the Immune Environment in Response to Therapy in Breast Cancer | recruiting | — | 300 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT06277219 | A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)(LIGHTSPEED-1) | recruiting | Phase 1 / Phase 2 | 150 | Latticon Antibody Therapeutics, IncINDUSTRY | 2 | Jul 8, 2025 | clinicaltrials |
| NCT05797805 | A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma | recruiting | Phase 1 / Phase 2 | 178 | Iterion TherapeuticsINDUSTRY | 2 | Jul 4, 2025 | clinicaltrials |
| NCT05789433 | Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer(RESTORE) | recruiting | N/A | 70 | AdventHealth Translational Research InstituteOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT06669117 | FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations | recruiting | Phase 1 / Phase 2 | 140 | Pierre Fabre MedicamentINDUSTRY | 9 | Jul 2, 2025 | clinicaltrials |
| NCT06415487 | ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR) | recruiting | Phase 1 | 30 | Acepodia Biotech, Inc.INDUSTRY | 2 | Jul 1, 2025 | clinicaltrials |
| NCT07045103 | A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study(ON-SITE) | recruiting | — | 900 | Invenio Imaging Inc.INDUSTRY | 1 | Jul 1, 2025 | clinicaltrials |
| NCT06163391 | A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer | recruiting | Phase 1 | 40 | SOTIO Biotech AGINDUSTRY | 5 | Jun 29, 2025 | clinicaltrials |
| NCT06988774 | Assessment of Tubal Occlusion During Minimally Invasive Myomectomy(ATOM) | recruiting | N/A | 50 | Medstar Health Research InstituteOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT03175224 | APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors(SPARTA) | recruiting | Phase 2 | 497 | Apollomics Inc.INDUSTRY | 11 | Jun 27, 2025 | clinicaltrials |
| NCT06240728 | A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2 | recruiting | Phase 1 | 144 | NextPoint Therapeutics, Inc.INDUSTRY | 2 | Jun 27, 2025 | clinicaltrials |
| NCT06570642 | eMOTION: Examining Affective Mechanisms in Physical Activity Engagement | recruiting | N/A | 280 | University of Southern CaliforniaOTHER | 1 | Jun 27, 2025 | clinicaltrials |
| NCT05785754 | DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors | recruiting | Phase 1 | 320 | DynamiCure BiotechnologyINDUSTRY | 4 | Jun 26, 2025 | clinicaltrials |
| NCT06869512 | Cooperative Extension and Cancer Survivorship(SUCCESS) | recruiting | N/A | 80 | University of OklahomaOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT05768269 | A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product | recruiting | — | 375 | Century Therapeutics, Inc.INDUSTRY | 1 | Jun 25, 2025 | clinicaltrials |
| NCT05879367 | Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma | recruiting | Phase 1 | 66 | Orbus Therapeutics, Inc.INDUSTRY | 1 | Jun 25, 2025 | clinicaltrials |
| NCT02285582 | International Rare Histiocytic Disorders Registry (IRHDR)(IRHDR) | recruiting | — | 400 | The Hospital for Sick ChildrenOTHER | 9 | Jun 24, 2025 | clinicaltrials |
| NCT07030348 | Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study | recruiting | — | 263 | Do Hyun ParkOTHER | 2 | Jun 22, 2025 | clinicaltrials |
| NCT06351527 | Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies | recruiting | Phase 1 | 78 | InnoCare Pharma Inc.INDUSTRY | 3 | Jun 19, 2025 | clinicaltrials |
| NCT06568692 | A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer | recruiting | Phase 2 | 90 | Processa PharmaceuticalsINDUSTRY | 1 | Jun 19, 2025 | clinicaltrials |
| NCT06785324 | Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)(NEOMA ALL) | recruiting | N/A | 20 | University of ChicagoOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT06789601 | Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository | recruiting | Phase 1 / Phase 2 | 100 | Brigham and Women's HospitalOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT02843945 | Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source | recruiting | Phase 1 / Phase 2 | 80 | CivaTech OncologyINDUSTRY | 1 | Jun 17, 2025 | clinicaltrials |
| NCT06937996 | Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System- | recruiting | — | 25 | Englewood Hospital and Medical CenterOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07021885 | NLit and Outcomes in HNC Survivor-Caregiver Dyads | recruiting | — | 150 | University of Kansas Medical CenterOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT02328677 | ColoCare Study - Colorectal Cancer Cohort | recruiting | — | 5,000 | University of UtahOTHER | 2 | Jun 13, 2025 | clinicaltrials |
| NCT05253495 | Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma(RADICAL) | recruiting | Phase 2 | 80 | New York Medical CollegeOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT06875700 | Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients | recruiting | — | 300 | University of UtahOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT05108090 | Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck | recruiting | N/A | 94 | Indiana UniversityOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT04412616 | ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies | recruiting | Phase 1 | 60 | Changchun Intellicrown Pharmaceutical Co. LTDINDUSTRY | 2 | Jun 10, 2025 | clinicaltrials |
| NCT06005324 | Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer | recruiting | Phase 1 | 36 | University of ChicagoOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT06215508 | Geriatric Assessment and Technology Evaluation in Prostate Cancer | recruiting | — | 120 | University of ChicagoOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT06515470 | Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer | recruiting | Phase 1 | 82 | Biotheryx, Inc.INDUSTRY | 1 | Jun 6, 2025 | clinicaltrials |
| NCT05241249 | Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma | recruiting | Phase 2 | 37 | Susan E. BatesOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT06746623 | Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux | recruiting | N/A | 400 | Louis Stokes VA Medical CenterFED | 1 | Jun 5, 2025 | clinicaltrials |
| NCT06904313 | Ultralow Dose PET Imaging for PSMA Expression | recruiting | Phase 2 | 200 | Akiva MintzOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT06956391 | Ultralow Dose PET Imaging of 18F-FDG Uptake | recruiting | Phase 2 | 200 | Akiva MintzOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT06119685 | IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers | recruiting | Phase 1 / Phase 2 | 128 | Indapta Therapeutics, INC.INDUSTRY | 1 | Jun 3, 2025 | clinicaltrials |
| NCT06603844 | First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor. | recruiting | Phase 1 / Phase 2 | 156 | Corbus Pharmaceuticals Inc.INDUSTRY | 2 | Jun 3, 2025 | clinicaltrials |
| NCT07001592 | Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors(RIOT3) | recruiting | Phase 1 | 18 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)OTHER | 1 | Jun 3, 2025 | clinicaltrials |
| NCT06355336 | Real World Prostate Cancer Registry(RWPCR) | recruiting | — | 1,000 | Cincinnati Cancer AdvisorsNETWORK | 1 | May 31, 2025 | clinicaltrials |
| NCT06564571 | Artificial Intelligence in Endoscopic Ultrasound | recruiting | — | 310 | Orlando Health, Inc.OTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT06999954 | Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform(SDS-GPS) | recruiting | — | 8,000 | Shwachman-Diamond Syndrome Alliance IncOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT05805436 | Preop Laxatives in Robotic Urologic Surgery | recruiting | Phase 4 | 240 | Chad R. TracyOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT06997185 | Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs | recruiting | N/A | 3,000 | London School of Economics and Political ScienceOTHER | 1 | May 30, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials